Experiments with chronic genetic loss of PDK4 indicate that it may have tumor-suppressive functions, whereas, acute inhibition of all PDKs with agents such as DCA yields a therapeutic effect based on prior experiments [24]. This evidence concerns the gene PDK4 and neoplasm.